Status:
UNKNOWN
Nasopharynx Microbiota Component and in Vitro Cytokines Production in Coronavirus Disease (COVID-19)
Lead Sponsor:
Başakşehir Çam & Sakura City Hospital
Conditions:
Covid19
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators will study nasopharunx microbiota composition, RNA sequences and in vitro cytokines production by peripheral blood cells of COVID-19 patients (both mild-moderate and severe cases) (c...
Detailed Description
The investigators will compare study parameters (basal) between mild-moderate and severe COVID-19 patients and with other study groups (i.e. convalescent and healthy controls). Nasopharunx microbiota ...
Eligibility Criteria
Inclusion
- Ability to give a written consent
Exclusion
- In ability to give a written consent
- Using of medications that affect the results of study parameters
- Presence of malignancy or tuberculosis
Key Trial Info
Start Date :
December 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2021
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04708912
Start Date
December 15 2020
End Date
April 1 2021
Last Update
March 24 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Bakirkoy Dr.sadi Konuk Training and Research Hospital
Istanbul, Turkey (Türkiye), 34100
2
Bakirkoy Dr.sadi Konuk Training and Research Hospital
Istanbul, Turkey (Türkiye)